chemotherapy

Open Access
Malignant Triton Tumor of the Distal Femur: A Case Report and Review of the Literature
YOSHITAKA BAN, NAOTO OEBISU, HANA YAO, NAOKI TAKADA, MANABU HOSHI, HIROAKI NAKAMURA and KENICHI KOHASHI

In Vivo November 2024, 38 (6) 3112-3116; DOI: https://doi.org/10.21873/invivo.13796
Open Access
Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases
RYO SATO, YUTO MATSUSHITA, ASUKA SANO, KYOHEI WATANABE, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, ATSUSHI OTSUKA and HIDEAKI MIYAKE

In Vivo July 2024, 38 (4) 1859-1864; DOI: https://doi.org/10.21873/invivo.13640
Open Access
Optimal Number of Cycles of First-line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
AKINORI MINATO, DAICHI OHNO, KAZUKI MUROOKA, YUTAKA OKUMURA, TOMOHISA TAKABA, KATSUYOSHI HIGASHIJIMA, YUJIRO NAGATA, IKKO TOMISAKI, KENICHI HARADA and NAOHIRO FUJIMOTO

In Vivo July 2024, 38 (4) 1927-1934; DOI: https://doi.org/10.21873/invivo.13648
Open Access
Chemotherapy and COVID-19 Vaccination in Patients With Gastrointestinal Cancer
MITSUKUNI SUENAGA, SHINICHI YAMAUCHI, RYO MORIKAWA, RIKA NOJI, YOSHIHITO KANO, MASANORI TOKUNAGA and YUSUKE KINUGASA

In Vivo May 2024, 38 (3) 1278-1284; DOI: https://doi.org/10.21873/invivo.13566
Open Access
Efficacy of Platinum-based Chemotherapy in Patients With Metastatic Urothelial Carcinoma With Variant Histology
AKINORI MINATO, KAZUKI MUROOKA, YUTAKA OKUMURA, TOMOHISA TAKABA, KATSUYOSHI HIGASHIJIMA, YUJIRO NAGATA, IKKO TOMISAKI, KENICHI HARADA and NAOHIRO FUJIMOTO

In Vivo March 2024, 38 (2) 873-880; DOI: https://doi.org/10.21873/invivo.13513
Open Access
[¹¹C] Methionine-PET Imaging as a Cancer Biomarker for Methionine Addiction and Sensitivity to Methionine-restriction-based Combination Chemotherapy
YUTARO KUBOTA, TOSHIHIKO SATO, QINGHONG HAN, CHIHIRO HOZUMI, SEI MORINAGA, KOHEI MIZUTA, TAKUYA TSUNODA and ROBERT M. HOFFMAN

In Vivo January 2024, 38 (1) 253-258; DOI: https://doi.org/10.21873/invivo.13432
Open Access
Pembrolizumab Monotherapy Versus Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma
MIOKO MATSUO, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, MASAHIKO TAURA, KAZUKI HASHIMOTO, RYUNOSUKE KOGO, RINA JIROMARU, TAKAHIRO HONGO, TOMOMI MANAKO and TAKASHI NAKAGAWA

In Vivo September 2023, 37 (5) 2188-2196; DOI: https://doi.org/10.21873/invivo.13318
Open Access
Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI)
SHINICHIRO OKAUCHI, GEN OHARA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, TAKESHI NUMATA, RYOTA NAKAMURA, TOMOHIRO TAMURA, NORIHIRO KIKUCHI, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, HIROFUMI SAKURAI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, TAKEO ENDO, HIROICHI ISHIKAWA, TAKAYUKI KABURAGI, HIROAKI SATOH, TORU SAKAMOTO and NOBUYUKI HIZAWA

In Vivo September 2023, 37 (5) 2203-2209; DOI: https://doi.org/10.21873/invivo.13320
Open Access
An Overview of the Roles of CDK4/6 Inhibitors in Metastatic Breast Cancer Elderly Patients
CARMEN PACILIO, GERARDO ROSATI, ANNA CRISPO, SABRINA BIMONTE, FRANCESCA DI RELLA, FRANCESCO NUZZO and MICHELINO DE LAURENTIIS

In Vivo July 2023, 37 (4) 1445-1449; DOI: https://doi.org/10.21873/invivo.13228
Open Access
Usefulness of a Medication Instruction Sheet for Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia
MAYAKO UCHIDA, ERIKA MOCHIZUKI, SHIGERU ISHIDA, NANA OZAWA, HIROKO YONEMITSU, HIDEKI OCHIAI, HANAE NAKAMURA, TAKEHIRO KAWASHIRI, KOJI KATO, NOBUAKI EGASHIRA, KOICHI AKASHI and ICHIRO IEIRI

In Vivo March 2023, 37 (2) 924-932; DOI: https://doi.org/10.21873/invivo.13164

Main menu

User menu

Search

chemotherapy

Pages